Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-11-063329
Filing Date
2011-11-14
Accepted
2011-11-14 06:44:50
Documents
11
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q v239862_10q.htm 10-Q 1144608
2 EX-31.1 v239862_ex31-1.htm EX-31.1 10079
3 EX-31.2 v239862_ex31-2.htm EX-31.2 10065
4 EX-32.1 v239862_ex32-1.htm EX-32.1 5812
5 EX-32.2 v239862_ex32-2.htm EX-32.2 5895
  Complete submission text file 0001144204-11-063329.txt   3354663

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT arni-20110930.xml EX-101.INS 417233
7 XBRL TAXONOMY EXTENSION SCHEMA arni-20110930.xsd EX-101.SCH 15742
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE arni-20110930_cal.xml EX-101.CAL 35457
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arni-20110930_def.xml EX-101.DEF 98858
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE arni-20110930_lab.xml EX-101.LAB 110872
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arni-20110930_pre.xml EX-101.PRE 105718
Mailing Address 4 CAMPUS DRIVE SECOND FLOOR PARSIPPANY NJ 07054
Business Address 4 CAMPUS DRIVE SECOND FLOOR PARSIPPANY NJ 07054 (862) 703-7175
Arno Therapeutics, Inc (Filer) CIK: 0001195116 (see all company filings)

EIN.: 522286452 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52153 | Film No.: 111197546
SIC: 2834 Pharmaceutical Preparations